The optimal surgical volume for anorectal melanoma: a retrospective analysis of the Russian Colorectal Cancer Society registry

Background. Anorectal melanoma is a rare malignancy without established standard treatment.
Aim. To analyse the Russian Colorectal Cancer Society melanoma registry and to assess optimal surgery with regard to the extent of the disease.
Materials and methods. A retrospective analysis of the Russian Colorectal Cancer Society registry was carried out during 2000–2020. Patients with cutaneous melanoma colonic metastases as well as patients with less than 6 months follow-up were excluded. Basic patient group characteristics, overall and disease-free survival (were analyzed depending on disease stage (by A. Stefanou) and surgery type.
Results. 16 patients had stage I–IIA, 24 – stage IIB, 29 patients – stage III and 24 patients – stage IV disease. Wide local excision was performed in 15 (93.8 %) patients with stage I–IIA, 15 (62.5 %) patients with stage IIB, 2 (6.9 %) patients with stage III, and 8 (33.3 %) patients with stage IV disease. Abdomino-perineal excision (APE) was performed in 0 patients with stage I–IIA, 7 (29.2 %) patients with stage IIB, 22 (75.9 %) patients with stage III, and 7 (29.2 %) patients with stage IV disease. 2-year overall survival was 74.5 % in stage I–IIA, 49.4 % in stage IIB, 64.3 % in stage III, and 10.4 % in stage IV disease; 2-year disease-free survival was 67 %, 23,4 %, 34,1 % in stage I–IIA, IIB, III disease accordingly. Median overall survival was 17.8 months, 38.3 months and 27.9 months for non-surgical treatment, wide local excision and APR in non-metastatic patients accordingly. Median disease-free survival was 6.0 months, 14.1 months and 12.0 months for non-surgical treatment, wide local excision and APR in non-metastatic patients accordingly.
Conclusions. APR should be considered in patients with stage IIB and stage III (by A. Stefanou) anorectal melanoma. Wide local excision is the preferred treatment in other patients.

1. Cheung M.C., Perez E.A., Molina M. et al. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg 2008;12(4):731–8. DOI:10.1007/s11605-007-0417-3

2. Newell F., Kong Y., Wilmott J. et al. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nat Commun 2019;10(1):3163. DOI:10.1038/s41467-019-11107-x

3. Yde S.S., Sjoegren P., Heje M., Stolle L. Mucosal melanoma: a literature review. Curr Oncol Rep 2018;20(3):28. DOI:10.1007/s11912-018-0675-0

4. Stefanou A., Nalamati S.P. Anorectal melanoma. Clin Colon Rectal Surg 2011;24(3):171–6.

5. Jutten E., Kruijff S., Francken A. et al. Survival following surgical treatment for anorectal melanoma seems similar for local excision and extensive resection regardless of nodal involvement. Surg Oncol 2021;37:101558. DOI:10.1016/j.suronc.2021.101558

6. Chen H., Cai Y., Liu Y. et al. Incidence, surgical treatment, and prognosis of anorectal melanoma from 1973 to 2011: a populationbased SEER analysis. Medicine (Baltimore) 2016;95(7):e2770.

7. Jutten E., Kruijff S., Francken A.B. et al. Surgical treatment of anorectal melanoma: a systematic review and meta-analysis. BJS Open 2021;5(6):zrab107. DOI:10.1093/bjsopen/zrab107

8. Menon H., Patel R., Cushman T. et al. Management and outcomes of primary anorectal melanoma in the United States. Future Oncol 2020;16(8):329–38.

9. Ogata D., Tsutsui K., Namikawa K. et al. Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era. J Cancer Res Clin Oncol 2022. DOI:10.1007/s00432-022-03933-2

10. Iddings D.M., Fleisig A., Chen S. et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol 2010;17(1):40–4. DOI:10.1245/s10434-009-0705-0

11. Smith H.G., Glen J., Turnbull N. et al. Less is more: a systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma. Eur J Cancer 2020;135:113–20. DOI:10.1016/j.ejca.2020.04.041

12. Matsuda A., Miyashita M., Matsumoto S. et al. Abdominoperineal resection provides better local control but equivalent overall survival to local excision of anorectal malignant melanoma: a systematic review. Ann Surg 2015;261(4):670–7. DOI:10.1097/SLA.0000000000000862

13. Taylor J.P., Stem M., Yu D. et al. Treatment strategies and survival trends for anorectal melanoma: is it time for a change? World J Surg 2019;43(7):1809–19. DOI:10.1007/s00268-019-04960-w

14. Kolosov A., Leskauskaite J., Dulskas A. Primary melanoma of the anorectal region: clinical and histopathological review of 17 cases. A retrospective cohort study. Colorectal Dis 2021;23(10):2706–13.

15. Wanebo H.J., Woodruff J.M., Farr G.H., Quan S.H. Anorectal melanoma. Cancer 19811;47(7):1891–900. DOI:10.1002/1097-0142(19810401)47:7<1891::aid-cncr2820470730>3.0.co;2-k

16. Mariolis-Sapsakos T., Malamitsi J., Yakoumakis E. et al. Is sentinel node mapping useful in anorectal melanoma? Hell J Nucl Med 2008;11(1):39–42.